Leerink downgrades BioNTech to “market perform” after 24% share rally
Leerink downgrades BioNTech to “market perform” after 24% share rallySource: Investing.com
Leerink downgrades BioNTech to “market perform” after 24% share rallySource: Investing.com
TSX futures muted amid extended drop in gold, silver pricesSource: Investing.com
Dow Jones, Nasdaq, S&P 500 weekly preview: More megacap earnings, jobs data on tapSource: Investing.com
BofA indicator implies S&P 500 return of 12% over the next 12 monthsSource: Investing.com
S&P 500 earnings revisions lag previous quarters amid choppy markets- RBCSource: Investing.com
Deutsche Bank upgrades AT&S to “buy,” lifts target to €50 on AI substrate demandSource: Investing.com
S&P 500 flat during earnings season despite solid sales growthSource: Investing.com
SOLV Energy launches IPO roadshow with shares priced at $22-$25Source: Investing.com
S&P dealer positioning could flip negative as CTA sell triggers loomSource: Investing.com
UBS expects UK equities to lag eurozone in 2026. Here is why.Source: Investing.com